SCHEMBL8042552

SCHEMBL8042552

O=CN(OCc1ccccc1)c1cccc2c(S(=O)(=O)Cl)cccc12

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NSD2 O96028 4/20 0.35
L3MBTL1 Q9Y468 2/20 0.34
CA2 P00918 2/20 0.34
CYP1A2 P05177 2/20 0.34
CYP2C19 P33261 2/20 0.34
TDP1 Q9NUW8 2/20 0.34
HTT P42858 1/20 0.34
HIF1A Q16665 1/20 0.34
NPC1 O15118 1/20 0.33
MAPT P10636 1/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
AGTR1 P30556 1/20 0.33
HDAC3 O15379 1/20 0.32
HDAC1 Q13547 1/20 0.32
HDAC2 Q92769 1/20 0.32
HDAC6 Q9UBN7 1/20 0.32
NCOR2 Q9Y618 1/20 0.32
CA1 P00915 1/20 0.32
CA9 Q16790 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8395506 0.88 TTR (0.42) NSD2L3MBTL1CA2CYP1A2CYP2C19
SCHEMBL8060497 0.86 TTR (0.41) NSD2L3MBTL1CA2CYP1A2CYP2C19
SCHEMBL29892548 0.73 TYMS (0.40) L3MBTL1CA2CYP1A2CYP2C19TDP1
SCHEMBL8055249 0.73 TYMS (0.40) L3MBTL1CA2CYP1A2CYP2C19TDP1
SCHEMBL27498085 0.69 MEN1 (0.36) L3MBTL1CA2TDP1NPC1MAPT
SCHEMBL6936315 0.68 TSHR (0.41) L3MBTL1CA2CYP1A2CYP2C19TDP1
SCHEMBL14842559 0.67 FABP4 (0.50) L3MBTL1CA2TDP1HTTNPC1
SCHEMBL16335458 0.67 CA2 (0.47) NSD2L3MBTL1CA2CYP1A2CYP2C19
SCHEMBL29904571 0.67 CDK2 (0.46) NSD2L3MBTL1CA2CYP1A2CYP2C19
SCHEMBL3133065 0.67 CDK2 (0.46) NSD2L3MBTL1CA2CYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6083951-A FOR THE TREATMENT OF DISEASES OR MEDICAL CONDITIONS SUCH AS HYPERTENSION, PULMONARY HYPERTENSION, CARDIAC OR CEREBRAL CIRCULATORY DISEASE AND RENAL DISEASE ZENECA LIMITED (GB) 2000-07-04 US disclosed
EP-0752986-B1 N-HETEROCYCLYL SULPHONAMIDE DERIVATIVES AND THEIR USE AS ENDOTHELIN ANTAGONISTS ZENECA LTD (GB) 1999-05-19 EP disclosed
US-5861401-A TREATMENT OF CONGESTIVE HEART FAILURE ZENECA LIMITED (GB) 1999-01-19 US disclosed
EP-0752986-A1 N-HETEROCYCLYL SULPHONAMIDE DERIVATIVES AND THEIR USE AS ENDOTHELIN ANTAGONISTS ZENECA LIMITED (GB) 1997-01-15 EP disclosed
WO-1995026957-A1 N-HETEROCYCLYL SULPHONAMIDE DERIVATIVES AND THEIR USE AS ENDOTHELIN ANTAGONISTS ZENECA LIMITED (GB) 1995-10-12 WO disclosed